← All organizations

Iroko

For profitWebsite ↗

Also known as: Iroko Pharmaceuticals, LLC

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

First marketed drug

Last known activity

Dec 1, 2015

Timeline

2000s

Jan 1, 2007
Iroko— Founded

2010s

Jan 1, 2011
iCeutica— Acquired
Oct 22, 2015
meloxicam— NDA Secondary Org

Drugs by trial phase (5 distinct, 13 trials)

Phase 3 (4 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

naproxen

Indications

Studied for

Marketed drugs (1)

meloxicam

Subsidiaries (1 direct, 1 total across the full acquisition tree)

iCeutica

Recent trials (13)

NCT02633969Lead sponsorPhase 2Dec 1, 2015
NCT02405793Lead sponsorPhase 2May 1, 2015
NCT02424578Lead sponsorPhase 2May 1, 2015
NCT01801735Lead sponsorPhase 3Mar 1, 2013
NCT01787188Lead sponsorPhase 3Feb 1, 2013
NCT01626118Lead sponsorPhase 3May 1, 2012
NCT01543685Lead sponsorPhase 3Feb 1, 2012
NCT01510912Lead sponsorPhase 3Jan 1, 2012
NCT01461369Lead sponsorPhase 3Oct 1, 2011
NCT01462435Lead sponsorPhase 3Oct 1, 2011
NCT01229228Lead sponsorPhase 2Oct 1, 2010
NCT00985439Lead sponsorPhase 2Sep 1, 2009
NCT00964431Lead sponsorPhase 2Aug 1, 2009

Details

Founded: Philadelphia, PA, US Jan 1, 2007
Last known activity: Dec 1, 2015